No results for ‘’
Ambalal Sarabhai Enterprises Ltd
₹30.94
(0.16%)
Tue, 28 Jul 2026, 02:57 am
Health Technology
Pharmaceuticals: Major
24.5KAmbalal Sarabhai Enterprises Debt to Equity Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 62.57 | 0 | 12.31 | 8.71 | 0 | 0 | 0 | 0 | 0 | 0 | 1.06 | 0 | 62.59 | 25.77 | 10.38 | 4.61 | 5.66 | 13.73 | 61.35 | 54.47 |
| Price to book ratio | 3.06 | 1.86 | 3.15 | 1.02 | 1.49 | 1.05 | 0.84 | 1.09 | 0 | 0 | 1.32 | 3.76 | 3.07 | 3.58 | 3.26 | 1.83 | 2.23 | 1.20 | 2.55 | 1.92 |
| Price to sales ratio | 0.60 | 0.83 | 2.04 | 0.80 | 1.10 | 0.63 | 0.35 | 0.20 | 0.18 | 0.24 | 0.39 | 0.70 | 0.65 | 0.73 | 1.11 | 0.83 | 1.37 | 0.93 | 2.02 | 1.38 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27.91 | 0 | 0 | 16.02 | 0 | 6.86 | 0 | 35.50 | 24.70 | 29.48 | 54.38 | 0 |
| Enterprise value | 148Cr | 158Cr | 180Cr | 53.95Cr | 79.86Cr | 53.7Cr | 50.5Cr | 51.36Cr | 47.24Cr | 61.58Cr | 81.78Cr | 120Cr | 103Cr | 126Cr | 155Cr | 132Cr | 266Cr | 174Cr | 362Cr | 308Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24.04 | 0 | 44.32 | 11.21 | 19.06 | 56.52 | 24.95 |
| Debt to equity ratio | 2.11 | 1.40 | 0.60 | 0.14 | 0.26 | 0.45 | 0.81 | 2.17 | 0 | 0 | 1.22 | 1.67 | 1.63 | 1.31 | 0.69 | 0.38 | 0.22 | 0.35 | 0.34 | 0.36 |
| Return on equity % | 6.20 | -69.70 | 22.12 | 11.54 | -0.44 | -21.84 | -25.55 | -67.37 | -256.13 | 0 | 328.25 | -57.04 | 5.55 | 14.87 | 37.30 | 49.48 | 48.74 | 9.13 | 4.25 | 3.56 |
Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio
The Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio is a key financial metric used by investors to evaluate Ambalal Sarabhai Enterprises Ltd's valuation, profitability, and overall financial performance. Tracking the Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Ambalal Sarabhai Enterprises Ltd (NSE: AMBASARABH, BSE: 500009) is currently trading at ₹30.94, with a market capitalization of ₹237.26Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio is essential for fundamental analysis.
Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio Current Value
The current Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio stands at 0.36.
The latest Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio Historical Trend
The Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio has shown the following historical trend:
- 2024: 0.36
- 2023: 0.34
- 2022: 0.35
- 2021: 0.22
- 2020: 0.38
The recent rise in Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio suggests strengthening valuation trends and improving market sentiment.
What Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio Indicates for Investors
The Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio plays a crucial role in understanding the company's financial health and valuation.
The D/E ratio measures financial leverage and balance sheet strength.
Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio Analysis Summary
The Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Ambalal Sarabhai Enterprises Ltd Debt to Equity Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.